Physicians Can Achieve High Patient Comfort When Utilizing Entellus Devices
Five studies reported pain scores for office based balloon dilation procedures. Four studies utilized Entellus devices; one study was sponsored by Acclarent, Inc. and utilized Relieva Solo Pro. All five studies utilized a 0 (no pain) to 10 (severe pain) discomfort scale.
For the Entellus studies, patients overall mean procedure pain levels were low—2.8.
|Clinical Study||n||Average Pain Score
(0=No Pain; 10=Severe Pain)
|XprESS Maxillary Only||21||1.8*|
|RELIEF (In-office FinESS)||69||3.2|
|BREATHE I (In-office FinESS)||19||2.7|
|ORIOS2 (Acclarent in-office)||198||4.5|
Learn More about Ensuring Patient Comfort
In-office, multisinus balloon dilation: 1-Year outcomes from a prospective, multicenter, open label trial.
Gould J; Alexander I; Tomkin E; Brodner D. American Journal of Rhinology & Allergy doi: 10.2500/ajra.2014.28.4043.
XprESS Maxillary Only
In-office balloon dilation: Procedure techniques and outcomes using a malleable multi-sinus dilation tool.
Gould JD. ENT Journal. Vendome Healthcare Media, 19 Dec 2012.
In-office stand-alone balloon dilation of maxillary sinus ostia ethmoid infundibula in adults with chronic or recurrent acute rhinosinusitis: A prospective, multi-institutional study with 1-year follow-up.
Levine S, Truitt T, Schwartz M, Atkins J. Ann Otol Rhinol Laryngol 122(11):665-671, 2013.
Two-year results: transantral balloon dilation of the ethmoid infundibulum.
Stankiewicz J, Truitt T, Atkins J, Winegar B, Cink P, Ravi J, Henderson D, Tami T. Intl Forum Allergy Rhinol. 2012 May-June; 2(3): 199-206.
Office-based balloon sinus dilation: a prospective, multicenter study of 203 patients.
Karanfilov B, Silvers S, Pasha R, Sikan A, Shikani A, Sillers MJ. Int Forum Allergy Rhinol. 2012 Nov 7; doi: 10.1002/alr.21112.